| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
Figure 3. Grade 2 (RTOG/EORTC) dysphagia-free survival after daytime pulsed dose rate (PDR) brachytherapy for re-irradiation of patients with recurrent oesophageal cancer. The endpoint of this analysis was the occurrence of grade 2 dysphagia (unable to take solid food normally, swallowing semi-solid food, dilatation may be indicated) during follow-up.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |